The Use of Magnetic Endoscopic Imaging for Improving Quality Indicators in Outpatient Colonoscopy

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01480830

Acronym

SCOPE GUIDE

Enrollment

633

Registered

2011-11-29

Start date

2012-01-31

Completion date

2013-10-31

Last updated

2024-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonoscopy

Keywords

Quality, indicators

Brief summary

Colonoscopy is an important procedure for diagnosing and treating diseases of the colon. In Canada, up to 13% all colonoscopies do not examine the full colon and are therefore incomplete. Incomplete colonoscopies happen for a number of reasons but are often due to twists and turns in the colon that make the colonoscopy difficult to perform and uncomfortable for the patient. This randomized study is being done to test a new colonoscopy system called the Scope Guide that shows an exact 3-dimensional picture of how the colonoscopy is positioned in the patient's abdomen. We hypothesize that the use of the Scope Guide for colonoscopy will improve measures of colonoscopy quality including rate of complete examination, patient comfort, polyp detection rate, insertion time, amount of sedation required, and need for abdominal compression.

Interventions

DEVICEMagnetic Endoscopic Imaging (MEI) colonoscopy

Colonoscopy using the Scope Guide system (Olympus Canada Inc.) by

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Participants must be over the age of 18 presenting for out-patient colonoscopy to the endoscopy unit at the VG Site.

Exclusion criteria

* Inability or unwillingness to provide written informed consent. * Previous incomplete or difficult colonoscopy (i.e. independent indication for use of Scope Guide). * Colonoscopist not participating in trial. * Current pregnancy. * Cardiac pacemaker or any other type of implantable stimulator. * Previous colectomy, hemicolectomy, segmental colon resection, or ileocecal resection.

Design outcomes

Primary

Measure	Time frame
Cecal intubation rate	baseline

Secondary

Measure	Time frame
Patient comfort	baseline
Amount of sedation required	baseline
Polyp detection rate	baseline
Use of abdominal compression	baseline
Insertion time	baseline

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026